Viridian Therapeutics, Inc.\DE (VRDN) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to -$71.45.
- Viridian Therapeutics, Inc.\DE's Times Interest Earned rose 5472.21% to -$71.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$108.43, marking a year-over-year decrease of 71.65%. This contributed to the annual value of -$98.17 for FY2024, which is 2873.82% up from last year.
- As of Q3 2025, Viridian Therapeutics, Inc.\DE's Times Interest Earned stood at -$71.45, which was up 5472.21% from -$207.72 recorded in Q2 2025.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Times Interest Earned peaked at -$64.04 during Q4 2024, and registered a low of -$9693.7 during Q4 2021.
- Moreover, its 5-year median value for Times Interest Earned was -$160.18 (2025), whereas its average is -$813.09.
- Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Times Interest Earned tumbled by 182593.66% in 2021 and then skyrocketed by 9698.71% in 2022.
- Viridian Therapeutics, Inc.\DE's Times Interest Earned (Quarter) stood at -$9693.7 in 2021, then skyrocketed by 96.99% to -$292.06 in 2022, then soared by 73.28% to -$78.03 in 2023, then increased by 17.94% to -$64.04 in 2024, then decreased by 11.58% to -$71.45 in 2025.
- Its last three reported values are -$71.45 in Q3 2025, -$207.72 for Q2 2025, and -$160.18 during Q1 2025.